Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.

Mattia LongoniPietro ScilipotiChiara ReGiuseppe RosielloLuigi Nocera Francesco PellegrinoGiuseppe BasileMario de AngelisLeonardo QuartaGiusy BurgioAndrea NecchiAntonio CigliolaArturo ChitiMaria PicchioAlessia d'ArmaAlberto BrigantiFrancesco Montorsi Marco Moschini

Published in: BJU international (2024)

In eight out of 10 patients with negative preoperative 18F-FDG PET/CT, pN0 disease was confirmed at final pathology. No differences were found based on NAC vs NAI treatment. These findings suggest that 18F-FDG PET/CT could play a role in the preoperative evaluation of nodal metastases in BCa patients, although its cost-effectiveness is uncertain.

Keyphrases

lymph node
end stage renal disease
patients undergoing
ejection fraction
newly diagnosed
neoadjuvant chemotherapy
chronic kidney disease
transcription factor
peritoneal dialysis
sentinel lymph node
early stage
replacement therapy
insulin resistance
rectal cancer
smoking cessation
patient reported